Paul Hastings Advised Stifel as Book-Running Manager on Precigen’s Common Stock Offering

Paul Hastings advised Stifel as the sole book-running manager in connection with Precigen, Inc.’s underwritten public offering of common stock. The offering is expected to close on August 9, 2024, subject to customary closing conditions.

Co-head of Equity Capital Markets and Co-chair of the Corporate Life Sciences Group Seo Salimi and Securities and Capital Markets partner Will Magioncalda led the Paul Hastings team, which also included associates Lauren Zhang and Adam Swank.

More details can be found here.

About Paul Hastings

With widely recognized elite teams in finance, mergers & acquisitions, private equity, restructuring and special situations, litigation, employment, and real estate, Paul Hastings is a premier law firm providing intellectual capital and superior execution globally to the world’s leading investment banks, asset managers, and corporations.